Company / Gross Profit
TREACE MEDICAL CONCEPTS, INC. Gross Profit History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$151.9M
FY2025
5-year range
$31.8M / $151.9M
FY2021-FY2025
Trend
+30.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has increased for 4 consecutive years, from $32M in FY2021 to $152M in FY2025.
Based on SEC 10-K filings.
$152M in FY2025 with a 3-year CAGR of +50.1%.
Improved from $78M to $152M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +50.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- TREACE MEDICAL CONCEPTS, INC.'s gross profit has grown for 4 consecutive years.
- 3-year CAGR of +50.1%, indicating consistent growth.
- In FY2025, gross profit increased 30.6% year-over-year.
- Lowest gross profit in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $151.9M | +30.6% |
| FY2024 | $116.3M | +50.0% |
| FY2023 | $77.5M | +72.7% |
| FY2022 | $44.9M | +41.2% |
| FY2021 | $31.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026